AVOPEF vs PADCEV

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. AVOPEF and PADCEV are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AVOPEF	PADCEV
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ETOPOSIDE	ENFORTUMAB VEDOTIN-EJFV
Manufacturer	Avyxa Holdings	Astellas
Dosage forms	Injectable	Injectable
Drug class	Topoisomerase Inhibitor	—
Boxed warning	Boxed warning	Boxed warning
Treats	Urinary Bladder Neoplasms, Brain Neoplasms, Lung Neoplasms	Urinary Bladder Neoplasms

avopef padcev

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

ETOPOSIDE

ENFORTUMAB VEDOTIN-EJFV

Manufacturer

Avyxa Holdings

Astellas

Dosage forms

Injectable

Drug class

Topoisomerase Inhibitor

—

Boxed warning

Treats

Urinary Bladder Neoplasms, Brain Neoplasms, Lung Neoplasms

Urinary Bladder Neoplasms

Frequently asked questions

What is the difference between Avopef and Padcev?

Avopef contains Etoposide, while Padcev contains Enfortumab Vedotin-Ejfv — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.